Open | $5.930 |
Close | $5.670 |
Volume / Avg. | 903.881K / 683.964K |
Day Range | 5.575 - 5.995 |
52 Wk Range | 1.370 - 9.800 |
Market Cap | $297.518M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 5.21% |
Days to Cover | 1.89 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kodiak Sciences (NASDAQ: KOD) through any online brokerage.
Other companies in Kodiak Sciences’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), bluebird bio (NASDAQ:BLUE), TScan Therapeutics (NASDAQ:TCRX), Opthea (NASDAQ:OPT) and Monte Rosa Therapeutics (NASDAQ:GLUE).
The latest price target for Kodiak Sciences (NASDAQ: KOD) was reported by UBS on Thursday, December 21, 2023. The analyst firm set a price target for 3.00 expecting KOD to fall to within 12 months (a possible -47.09% downside). 10 analyst firms have reported ratings in the last year.
The stock price for Kodiak Sciences (NASDAQ: KOD) is $5.67 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Kodiak Sciences.
Kodiak Sciences’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Kodiak Sciences.
Kodiak Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.